Deborah Knobelman
2022
In 2022, Deborah Knobelman earned a total compensation of $1.1M as Chief Financial Officer, Treasurer and Head of Corporate Development at Senti Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $169,992 |
|---|---|
| Option Awards | $428,208 |
| Salary | $424,981 |
| Stock Awards | $75,000 |
| Other | $5,244 |
| Total | $1,103,425 |
Knobelman received $428.2K in option awards, accounting for 39% of the total pay in 2022.
Knobelman also received $170K in non-equity incentive plan, $425K in salary, $75K in stock awards and $5.2K in other compensation.
Rankings
In 2022, Deborah Knobelman's compensation ranked 2,840th out of 5,760 executives tracked by ExecPay. In other words, Knobelman earned more than 50.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,840 out of 5,760 | 51st |
Division Manufacturing | 1,583 out of 3,136 | 50th |
Major group Chemicals And Allied Products | 733 out of 1,422 | 49th |
Industry group Drugs | 685 out of 1,323 | 48th |
Industry Biological Products, Except Diagnostic Substances | 166 out of 291 | 43rd |
Source: SEC filing on April 28, 2023.
Knobelman's colleagues
We found two more compensation records of executives who worked with Deborah Knobelman at Senti Biosciences in 2022.